학술논문

Efficacy and safety of a new original interleukin 17a inhibitor in the treatment of patients with active ankylosing spondylitis: Results of a basic (bcd-085-3/ailas) and extended (bcd-085-3ext/ailas-II) phase II clinical trial
Document Type
Article
Source
In: Nauchno-Prakticheskaya Revmatologiya. (Nauchno-Prakticheskaya Revmatologiya, 2019, 57(6):668-677)
Subject
Language
English
Russian
ISSN
19954492
19954484